In-depth coverage of regulatory change and licensing frameworks across the UK & EU.
Last week, the first Cannabis Health Symposium to take place in Germany saw the local industry’s leading telemedicine and pharmacy voices pull apart the rationale behind proposed medical cannabis restrictions.
Frances’ incoming medical cannabis framework is expected to take the final step before it can be signed into law in the ‘coming weeks’.
Germany’s coalition government has retreated further on its controversial medical cannabis reimbursement reforms as it faces mounting questions over how and why the law came to be.
Initial findings from the Netherlands’ landmark ‘controlled cannabis supply chain experiment’ were submitted to the House of Representatives on September 9, the first published findings since the T0 baseline report, published in March 2024 (covering data collected in 2022).
By Ben Stevens, with additional reporting by Nicole Farah, Managing Director of Americana Communications.
The long-term future of Britain’s CBD sector ‘really will lie with EU authorisations’, the chair of the Food Standards Agency (FSA) has told its board, a candid admission that the domestic regime the industry has chased for six years may ultimately be superseded by Brussels.
Pressure is piling on the UK’s Advisory Council on the Misuse of Drugs (ACMD) to publish its highly anticipated review of the country’s medical cannabis framework.
Portugal’s medicines regulator has defended a year of tightened oversight and extended licensing delays throughout the country’s medical cannabis sector, telling operators that export certificates are now issued within 12 days and that the enforcement which unsettled the market stemmed from record-keeping and traceability failures rather than problems with the product itself.
Britain is on course to become the first country in the world to formally authorise cannabidiol (CBD) as a novel food, as the Food Standards Agency (FSA) recommends three applications for ministerial approval in a move that could bring an estimated 3,000 products into legal compliance.
